Perioperative opiate requirements in children with previous opiate infusion

Jeffrey J Fanning1, Astrid G Stucke, Melissa A Christensen

  • 1Pediatric Acute Care Associates of North Texas, PA, Pediatric Critical Care Medicine, Medical City Children's Hospital, Dallas, TX, USA.

Paediatric Anaesthesia
|November 11, 2011
PubMed

Insights

Children previously on long-term opiates who were weaned off them did not require higher pain medication doses for surgery. This suggests opiate tolerance alone doesn't necessitate altered perioperative pain management strategies.

Area of Science:

  • Pediatric critical care medicine
  • Pain management
  • Pharmacology

Background:

  • Critically ill children often require continuous opiate infusions, potentially leading to tolerance.
  • Developing tolerance necessitates opiate weaning strategies to prevent withdrawal symptoms.
  • Children with prior opiate exposure may undergo subsequent surgical procedures, raising questions about perioperative pain management.

Purpose of the Study:

  • To investigate if pediatric patients previously exposed to continuous opiates and subsequently weaned require higher perioperative opiate doses compared to opioid-naïve controls.
  • To determine if a history of opiate tolerance impacts future perioperative pain management needs in children.

Main Methods:

  • Retrospective study at a tertiary children's hospital.
  • Compared 31 opiate-exposed, weaned children (≥10 days continuous use, weaned, no withdrawal signs for ≥72h pre-op) with 31 age- and case-matched opioid-naïve controls.
  • Analyzed medication records for perioperative opiate use (morphine equivalents per kilogram body weight); used Wilcoxon rank sum test for comparisons.

Main Results:

  • Perioperative opiate requirements were not significantly different between opiate-exposed patients (median 0.14 MSEQ·kg⁻¹) and opioid-naïve controls (median 0.10 MSEQ·kg⁻¹).
  • P-value for comparison was 0.19, indicating no statistically significant difference.
  • Pain scores indicated patients were generally comfortable during the perioperative period.

Conclusions:

  • Successfully weaned pediatric patients with a history of prolonged opiate use have similar perioperative opiate requirements as opioid-naïve patients.
  • A history of prolonged opiate use, without active withdrawal, does not, in itself, mandate specialized pain management protocols for subsequent procedures.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...